MYD88 and breast carcinoma: In this regard, previous studies have reported suppression of LPS-induced migration and invasion of breast cancer cells after targeting MyD88-dependent signaling pathways, for instance, MyD88/GSK-3β/Snail and MyD88/NF-κB/Snail [44].